COLOMBATTO MARTIN J 4

What Happened Martin J. Colombatto, a director of Catheter Precision, Inc. (VTAK), was granted 40,000 derivative securities (reported as an acquisition, code A) on 2026-03-26. The Form 4 reports an acquisition price of $0.00 per share and a reported value of $0. The filing classifies the award as a derivative transaction rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-26; Form 4 filed: 2026-03-30 (timely filing).
• Amount: 40,000 derivative shares/units granted at $0.00 per share (reported value $0).
• Shares/units owned after transaction: not specified in the provided filing details.
• Footnote: the award’s options vest 100% on the 180-day anniversary of the grant date.
• No indication in the filing of immediate exercise, sale, tax withholding, or a 10b5-1 plan.

Context This was an award/grant (an acquisition of derivative securities), not a sale. For retail investors, note that the grant is subject to a 180-day vesting period before Colombatto fully earns the award; the filing does not show any immediate cash exercise or sale. Awards to directors are common as part of compensation and do not by themselves indicate the insider’s near‑term trading intentions.